Body composition by DXA in chronic liver disease.

被引:0
|
作者
Soo, S
Hussaini, SH
Oldroyd, B
Stewart, SP
Smith, M
Losowsky, MS
机构
[1] St James Univ Hosp, Acad Div Med, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Ctr Bone & Body Composit Res, Leeds, W Yorkshire, England
关键词
D O I
10.1016/S0016-5085(98)80172-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
G0172
引用
收藏
页码:A42 / A42
页数:1
相关论文
共 50 条
  • [21] Chronic Kidney Disease - Chronic Liver Disease. An Immunologic Cross-talk
    Gluhovschi, Gh.
    Petrica, Ligia
    Timar, Sporea R.
    Curescu, Manuela
    Velciov, Silvia
    Gluhovschi, Cristina
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2015, 53 (01) : 3 - 12
  • [22] Body composition in chronic kidney disease
    Johansen, Kirsten L.
    Lee, Carol
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (03): : 268 - 275
  • [23] Body composition in patients with chronic obstructive pulmonary disease.: Comparison between bioelectrical impedance analysis and anthropometry
    Doré, MF
    Kouchakji, B
    Orvoën-Frija, E
    Rochemaure, J
    Laaban, JP
    REVUE DES MALADIES RESPIRATOIRES, 2000, 17 (03) : 665 - 670
  • [24] Adherence to vaccination guidelines in patients with chronic liver disease.
    Arguedas, MR
    McGuire, BM
    Fallon, MB
    Abrams, GA
    Bloomer, JR
    HEPATOLOGY, 2000, 32 (04) : 314A - 314A
  • [25] Serum thrombopoietin and hepatosplenomegaly in patients with chronic liver disease.
    Satoi, J
    Sanjyou, Y
    Takekuma, A
    Nekohashi, T
    Abe, T
    Tsuboi, Y
    Suzuki, N
    Kato, T
    Tahara, T
    Tanaka, T
    HEPATOLOGY, 1997, 26 (04) : 309 - 309
  • [26] Pathophysiological and clinical role of erythropoietin in chronic liver disease.
    Tacke, F
    Schöffski, P
    Ganser, A
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 2002, 36 (04) : 515A - 515A
  • [27] Ghrelin is a parameter of catabolism in patients with chronic liver disease.
    Tacke, F
    Brabant, G
    Kruck, E
    Horn, R
    Schöffski, P
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 2002, 36 (04) : 530A - 530A
  • [28] Interaction of ursodeoxycholate with glycyrrhizin on the treatment of chronic liver disease.
    Mitsuyoshi, H
    Nakashima, T
    Inaba, K
    Sakamoto, Y
    Iwai, M
    Okanoue, T
    Kashima, K
    GASTROENTEROLOGY, 1996, 110 (04) : A1266 - A1266
  • [29] Grip strength: Its role in chronic liver disease.
    Soo, S
    Hussaini, SH
    Oldroyd, B
    Stewart, SP
    Smith, M
    Losowsky, MS
    GASTROENTEROLOGY, 1998, 114 (04) : A43 - A43
  • [30] Adrenal dysfunction is associated with acute and chronic liver disease.
    Harry, R
    Auzinger, G
    Wendon, J
    HEPATOLOGY, 2001, 34 (04) : 194A - 194A